EUVIMEDEUVIMED entdecken
Crossref

The Effect of Prophylactic Use of NSAIDs on Acute Phase Reactions Induced by First-Time Zoledronic Acid Treatment for Osteoporosis

Qiuling Wang, Weiyang Zhang, Wencan Lu, Weipeng Ai iD

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280251367582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Qiuling Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shenzhen University General Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Zoledronic Acid, Anti-Inflammatory Agents, Non-Steroidal, Osteoporosis, Acute-Phase Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Zoledronic acid is a first-line treatment for primary osteoporosis, but its high acute-phase-reaction (APR) incidence can reduce patient compliance and long-term efficacy. Non-steroidal anti-inflammatory drugs (NSAIDs), with antipyretic and analgesic effects, can relieve APR symptoms like fever and muscle soreness caused by zoledronic acid. However, the role of prophylactic NSAID use in decreasing APRs remains controversial.

Objective

This study aims to evaluate the impact of NSAIDs on preventing zoledronic acid-related APRs to guide clinical practice.

Methods

Retrospective data of osteoporosis patients receiving zoledronic acid injection at Shenzhen University General Hospital from January 2023 to December 2024 were collected. A 1:2 propensity score matching (PSM) compared the APR incidences between the non-NSAIDs and NSAIDs groups.

Results

Among 351 cases (98 non-NSAIDs, 253 NSAIDs), 200 cases (79 non-NSAIDs, 121 NSAIDs) remained after PSM. The NSAIDs group had a lower overall APR incidence (38.0% vs. 53.2%, χ 2 = 4.451, P = .035). There was no significant difference in fever incidence (χ2 = 1.888, P = .169), but pain incidence was lower in the NSAIDs group (25.3% vs. 9.9%, χ 2 = 8.433, P = .004). Flurbiprofen axetil, ibuprofen, and etoricoxib showed similar APR—preventive effects. Conclusion and relevance: Prophylactic NSAIDs significantly reduce zoledronic acid-induced APRs, especially pain, but have no significant effect on preventing fever. The 3 NSAIDs also have comparable efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidAnti-Inflammatory Agents, Non-SteroidalOsteoporosisAcute-Phase ReactionBone Density Conservation AgentsHumansFemaleRetrospective StudiesAgedMiddle AgedAged, 80 and overMale

Stichwörter der Autor:innen

acute-phase-reactionnonsteroidal anti-inflammatory drugsprimary osteoporosiszoledronic acid

Substanzen

Zoledronic AcidAnti-Inflammatory Agents, Non-SteroidalBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Shenzhen University General Hospital, Shenzhen, China.
  • Department of Spine and Bone Diseases, Shenzhen University General Hospital, Shenzhen, China.

ORCID-Profile: Weipeng Ai

Zitieren

APA

Wang, Q., Zhang, W., Lu, W., & Ai, W. (2026). The Effect of Prophylactic Use of NSAIDs on Acute Phase Reactions Induced by First-Time Zoledronic Acid Treatment for Osteoporosis. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251367582

Vancouver

Wang Q, Zhang W, Lu W, Ai W. The Effect of Prophylactic Use of NSAIDs on Acute Phase Reactions Induced by First-Time Zoledronic Acid Treatment for Osteoporosis. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251367582

BibTeX
@article{Wang2026,
  author = {Wang, Qiuling and Zhang, Weiyang and Lu, Wencan and Ai, Weipeng},
  title = {The Effect of Prophylactic Use of NSAIDs on Acute Phase Reactions Induced by First-Time Zoledronic Acid Treatment for Osteoporosis},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280251367582}
}
Kostenlos starten →